Abstract:Short-chain fatty acids (SCFAs), especially butyrate, produced in mammalian intestinal tracts via fermentation of dietary fiber, are known biofunctional compounds in humans. However, the variability of fermentable fiber consumed on a daily basis and the diversity of gut microbiota within individuals often limits the production of short-chain fatty acids in the human gut. In this study, we attempted to enhance the butyrate levels in human fecal samples by utilizing butyl-fructooligosaccharides (B-FOS) as a novel prebiotic substance. Two major types of B-FOS (GF3-1B and GF3-2B), composed of short-chain fructooligosaccharides (FOS) bound to one or two butyric groups by ester bonds, were synthesized. Qualitative analysis of these B-FOS using Fourier transform infrared (FT-IR) spectroscopy, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS), nuclear magnetic resonance (NMR) and low-resolution fast-atom bombardment mass spectra (LR-FAB-MS), showed that the chemical structure of GF3-1B and GF3-2B were [O-(1-buty-β-D-fru-(2→1)-O-β-D-fru-(2→1)-O-β-D-fru-O-α-D-glu] and [O-(1-buty)-β-D-fru-(2→1)-O-β-D-fru-(2→1)-O-(4-buty)-β-D-fru-O-α-D-glu], respectively. The ratio of these two compounds was approximately 5:3. To verify their biofunctionality as prebiotic oligosaccharides, proliferation and survival patterns of human fecal microbiota were examined in vitro via 16S rRNA metagenomics analysis compared to a positive FOS control and a negative control without a carbon source. B-FOS treatment showed different enrichment patterns on the fecal microbiota community during fermentation, and especially stimulated the growth of major butyrate producing bacterial consortia and modulated specific butyrate producing pathways with significantly enhanced butyrate levels. Furthermore, the relative abundance of Fusobacterium and ammonia production with related metabolic genes were greatly reduced with B-FOS and FOS treatment compared to the control group. These findings indicate that B-FOS differentially promotes butyrate production through the enhancement of butyrate-producing bacteria and their metabolic genes, and can be applied as a novel prebiotic compound in vivo.

Evaluation of Potential Prebiotic Activity of a Novel Fucose-Containing Trisaccharide Prepared from Bacterial Exopolysaccharides

Structural characterization of a novel fucosylated trisaccharide prepared from bacterial exopolysaccharides and evaluation of its prebiotic activity

A Novel Glucofucobiose with Potential Prebiotic Activity Prepared from the Exopolysaccharides of Clavibacter Michiganensis M1.

Structural Characterization and Prebiotic Activity Evaluation of Novel Fucosylated Disaccharides Prepared from Bacterial Exopolysaccharides

Synthesis of Potential Prebiotic Α-Glucooligosaccharides Using Microbial Glucansucrase and Their in Vitro Fecal Fermentation.

Biochemical Characterization of a Novel Α-L-fucosidase from Pedobacter Sp. and Its Application in Synthesis of 3′-Fucosyllactose and 2′-Fucosyllactose

Effects of 2'-Fucosyllactose on the Composition and Metabolic Activity of Intestinal Microbiota from Piglets after in Vitro Fermentation

Effects of Degradation Products of Fucosylated Exopolysaccharide on Infant Gut Microflora

Production, Structural Characterization, and In Vitro Assessment of the Prebiotic Potential of Butyl-Fructooligosaccharides

In Vitro Assessment of Prebiotic Properties of Oligosaccharides Derived from Four Microbial Polysaccharides

Screening of Bifidobacteria with Probiotic Potential from Healthy Infant Feces by Using 2′-Fucosyllactose

Comparative Study of Prebiotics for Infants Using a Fecal Culture System: Insights into Responders and Non-Responders

2′-Fucosyllactose Promotes Bifidobacterium Bifidum DNG6 Adhesion to Caco-2 Cells

Synthesis and Evaluation of Antioxidant and Potential Prebiotic Activities of Acetylated and Butyrylated Fructo-Oligosaccharides

In Vitro Infant Faecal Fermentation of Low Viscosity Barley Β-Glucan and Its Acid Hydrolyzed Derivatives: Evaluation of Their Potential As Novel Prebiotics

Lactosucrose and Its Analogues Derived from Lactose and Sucrose: Influence of Structure on Human Intestinal Microbiota in Vitro

In Vitro Fermentation of Human Milk Oligosaccharides by Individual Bifidobacterium Longum-Dominant Infant Fecal Inocula.

Transcriptomic and Metabolomic Analysis of Prebiotics Utilization by Bifidobacterium Animalis

A 21-day safety evaluation of biotechnologically produced 3-fucosyllactose (3-FL) in neonatal farm piglets to support use in infant formulas

Prebiotic Effects of Oligosaccharides and Soluble Dietary Fiber on Infant Intestinal Flora

An In Vitro Colonic Fermentation Study of the Effects of Human Milk Oligosaccharides on Gut Microbiota and Short-Chain Fatty Acid Production in Infants Aged 0-6 Months